公开(公告)号：US20230382871A1

公开(公告)日：2023-11-30

申请号：US18027759

申请日：2021-09-22

Applicant: SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

Inventor： Jian DING ,  Wenhu DUAN ,  Hua XIE ,  Meiyu GENG ,  Caixia WANG ,  Zhengsheng ZHAN ,  Na GAO ,  Yang ZHANG

IPC: C07D231/56 ,  A61P35/00 ,  C07K16/28

CPC classification number: C07D231/56 ,  A61P35/00 ,  C07K16/2818 ,  C07K16/2827 ,  A61K2039/505

Abstract: Provided is the use of a CSF1R kinase inhibitor compound or a pharmaceutically acceptable salt thereof in the preparation of drugs for treating diseases related to the CSF1R kinase signal transduction pathway or drugs for regulating immunization.